These included hormones to treat TTR-HO-related neuroendocrine disorders: secondary or tertiary forms of adrenal deficiency, hypothyroidism, hypogonadism, growth hormone deficiency, and hypopituitarism as a combination of all. This evidence concerns the gene HMOX1 and hypogonadism.